Vice President – Chemistry, Manufacturing, and Control
Korsana Biosciences
Vice President – Chemistry, Manufacturing, and Control
Korsana Biosciences
Develops THETA-enabled neurodegenerative therapeutics
About Us
Korsana Biosciences is a private biopharmaceutical company advancing a pipeline of potential best-in-class therapies for neurodegenerative diseases. In partnership with Paragon Therapeutics, we have developed Therapeutic Targeting (THETA™), a novel blood-brain barrier-penetrant shuttle platform designed to enable dramatically higher drug concentration inside the brain and overcome the limitations of earlier shuttle technologies. Our lead program is KRSA-028, an investigational, shuttled antibody targeting amyloid beta designed to be a best-in-class treatment for Alzheimer’s disease. Our mission is to advance precision-engineered therapies, designed to address some of the biggest unmet needs in medicine. For more information, please visit www.korsana.com
Position Overview
The Vice President of CMC (Chemistry, Manufacturing, and Control) at Korsana Biosciences will develop, implement, and execute CMC strategy in support of a best-in-class portfolio of preclinical and clinical programs. This leader will oversee the planning and execution of outsourced CMC activities including biologics technical development, cGMP manufacturing, release and stability testing, and will work proactively with external suppliersincluding CDMOs and contract labs to define project scope, mitigate risks, and ensure successful delivery with regard to technical quality, timelines and budget. The VP will partner closely with Research, Supply Chain, Clinical, Quality, Regulatory, and Program Management to deliver quality products for preclinical studies and clinical trials and Module 3 Quality for regulatory submission and approval. The position requires strategic vision and hands-on experience managing early-stage biotech programs in a dynamic, fast-paced environment.
Responsibilities
Education & Experience
Skills & Attributes
The anticipated base salary range for this position is $300,000 - $340,000. This role may also be eligible for a target annual bonus and equity-based compensation, as well as participation in the company’s benefit programs. Actual compensation will depend on several factors, which may include, but are not limited to relevant years of experience, educational background, and geography.
Korsana Biosciences is the sixth groundbreaking company launched by Paragon Therapeutics, a premier biotech incubator founded by Fairmount Funds in 2021, known for its expertise in discovering and developing cutting-edge therapeutic assets in-house.
__
Korsana Biosciences is an Equal Opportunity Employer. We are committed to fostering a diverse, inclusive, and equitable workplace where all individuals are valued and respected. Employment decisions are based on qualifications, merit, and business needs, without regard to race, color, religion, gender, sexual orientation, national origin, disability, veteran status, or any other protected status.
[]
Develops THETA-enabled neurodegenerative therapeutics
Korsana Biosciences develops therapies for neurodegenerative diseases, with a focus on Alzheimer's disease. Its lead candidate KRSA-028 is a monoclonal antibody that targets amyloid beta and uses the THETA platform to shuttle across the blood-brain barrier, increasing brain exposure. THETA combines TfR1-based shuttling and Fc engineering to improve brain delivery and enable subcutaneous administration while aiming to reduce ARIA risks. The company plans to advance THETA-enabled therapies through clinical trials, with safety data expected in 2027 and initial amyloid clearance proof-of-concept by the end of 2027, supported by funding into 2028.
Explore more opportunities at Korsana Biosciences